EOM Pharmaceutical Holdings (IMUC, $0.11) was a top loser over the last three months, falling -2 to $0.11 per share. A.I.dvisor analyzed 835 stocks in the Biotechnology Industry for the 3-month period ending May 27, 2025, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend. A.I.dvisor found 411 similar cases when IMUC's price dropped within three months. In out of those 411 cases, IMUC's price went up during the following month. Based on these historical data, A.I. thinks the odds of a Downtrend reversal for IMUC are